Table I. The histopathology of ovarian masses included in the study in the training and test groups.
Histopathology | N (total N = 187) | |
Benign (n = 112) | Mature teratoma | 23 |
Endometrioma/endometriosis | 15 | |
Mucinous cystadenoma | 23 | |
Functional cyst | 5 | |
Ovarian fibroma | 6 | |
Serous cystadenoma | 21 | |
Serous cystadenofibroma | 13 | |
Other benign | 6 (1 tubal abscess, 1 Brenner tumour, 1 Multilocular peritoneal inclusion cyst MPIC, 1 Mucinous cystadenofibroma, 1 subserous adenomyoma, 1 hydrosalpinx) |
|
Malignant (n = 75) | Borderline mucinous tumour | 15 |
Borderline serous tumour | 6 | |
Serous cyst/adenocarcinoma | 28 | |
Mucinous cyst/adenocarcinoma | 3 | |
Endometrioid adenocarcinoma | 6 | |
Other ovarian cancer | 17 (1 Lymphoma, 7 metastatic tumours (3 intestinal, 1 breast, 1 pancreatic, 1 gastric, and 1 lung cancers), 1 leiomyosarcoma,1 stromal tumour, 1 germ cell tumour, 2 clear cell carcinomas, 2 carcinosarcomas, 1 immature teratomas, 1 endometrial cancer) |